I completed my PhD at the MRC Laboratory of Molecular Biology, working on a potential biomarker of mitochondrial dysfunction relevant to Parkinson's Disease. I now work in drug discovery research, utilising my mitochondrial biology and ubiquitin-related skills in early-stage target discovery and validation in neurodegenerative disease.